This week Qatar set a major precedent in growth and development in specialist care for children and women by opening the main hospital of Sidra Medicine, a specialty healthcare organisation and member of Qatar Foundation (QF).
Through strong partnerships with leading institutions in Qatar and around the world, Sidra Medicine helps to position Qatar as a leading centre of excellence in healthcare globally. As a landmark project located within Education City, Sidra Medicine is emblematic of QF’s investment in the health and wellbeing of Qatar’s community.
Sidra Medicine includes an outpatient clinic, a main hospital and a research institution. It is also an academic medical centre. It will provide comprehensive specialist healthcare services for children and young people and maternity care for women in Qatar and internationally. Sidra Medicine opened its hospital on January 14 with the launch of inpatient obstetrics services and several children’s services. The current schedule of inpatient services will be ramped up through mid-2018 to include more complex pediatric surgeries, specialist pediatric services in neurology and cardiology, among others, as well as deliveries, focusing on high-risk pregnancies.
With the aim of becoming a centre of excellence, Sidra Medicine has been designed to the highest international standards, with state-of-the-art medical equipment and sophisticated laboratories to nurture innovation and clinical advancement.
Once fully operational, Sidra Medicine will handle 275,000 outpatient appointments, 11,000 procedures, 100,000 emergency attendances and deliver over 9,000 babies per year, adding capacity to a rapidly growing population and delivering world-class specialist care. The hospital will include 10 operating theatres and 400 beds. It will become the leading children’s hospital in Qatar and will be the only specialist centre treating pregnant women with foetal complications.
Medical care at Sidra Medicine is supported by research aimed at advancing the understanding of the epidemiology and mechanisms of diseases for the people of Qatar. This will help develop personalized preventative, diagnostic and therapeutic tools and improve the health outcomes of the women, young people and children of Qatar.
Sidra Medicine’s research programme will help develop ground-breaking treatments, technologies and techniques, especially in the areas of Maternal Fetal Medicine, Genetics and Genomics and Maternal Diabetes and Metabolic Syndromes.
Sidra Medicine has already handled 117 cases through its international referrals office, since Outpatient Clinic opened in May 2016. It includes referrals from at least 15 regional and international countries. With its outstanding standards and services, Sidra Medicine is on a mission to be a beacon of learning, discovery and exceptional care, and to be ranked among the top academic medical centres of the world.
